The Pharmacophore of Short Cationic Antibacterial Peptides
Journal of Medicinal Chemistry2003Vol. 46(9), pp. 1567–1570
Citations Over TimeTop 10% of 2003 papers
Abstract
Cationic antibacterial peptides have been proclaimed as new drugs against multiresistant bacteria. Their limited success so far is partially due to the size of the peptides, which gives rise to unresolved issues regarding administration, bioavailability, metabolic stability, and immunogenicity. We have systematically investigated the minimum antibacterial motif of cationic antibacterial peptides regarding charge and lipophilicity/bulk and found that the pharmacophore was surprisingly small, opening the opportunity for development of short antibacterial peptides for systemic use.
Related Papers
- → DOSE-DEPENDENT EFFECTS OF ANTIBACTERIAL ACTIVITY OF SYNTHETIC PEPTIDES ISOLATED FROM GM-CSF ACTIVE CENTER(2014)
- Study on Antibacterial Peptides Application in Meat Products of Low Temperature(2006)
- A Study on Antibacterial Activity of Antibacterial Peptide From Lucilia sericata After Treatment at High Temperature(2005)
- Biological Properties and Preliminary Purification of Antibacterial Peptide from Tenebrio molitor(2009)
- Study on the Antibacterial Mechanism of a Glycine-Rich Antibacterial Peptide SK_(66) of Drosophila(2012)